Sipai Health Technology Co,

Sipai Health Technology Co, EBITDA per Share

The EBITDA per Share of Sipai Health Technology Co, (314.HK) as of Nov 21, 2026 is -0.39 CNY. In the previous year, EBITDA per Share was -0.33 CNY — a change of 18.73% (lower).

EBITDA per Share

-0.39CNY

YoY

18.73%

Last updated:

EBITDA per Share of Sipai Health Technology Co, is 2024 -0.39 CNY. EBITDA per Share of Sipai Health Technology Co, was 2023 -0.33 CNY. It decreases by 18.73% lower compared to the previous year.

The Sipai Health Technology Co, EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2020
-0.48 CNY
Jan 1, 2021
-0.86 CNY
Jan 1, 2022
-0.82 CNY
Jan 1, 2023
-0.33 CNY
Jan 1, 2024
-0.39 CNY
The Sipai Health Technology Co, EBITDA per Share history
YEAREBITDA per ShareYoY
-0.39CNY+18.73%
-0.33CNY-59.86%
-0.82CNY-4.59%
-0.86CNY+79.37%
-0.48CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sipai Health Technology Co, Stock analysis

What does Sipai Health Technology Co, do? Sipai Health Technology Co., Ltd. generates revenue through its Specialty Pharmacy Business, which operates offline specialty pharmacies and distributes pharmaceutical products to pharmaceutical companies and distributors. The Physician Research Assistance Business offers integrated services to pharmaceutical companies for producing clinical trial data that meets regulatory standards, supporting their progression to later clinical phases or regulatory approvals. The Health Insurance Services Business provides insurance brokerage services, distributing various health and life insurance products on behalf of insurance carriers. These segments collectively serve pharmaceutical companies, healthcare providers, and insurance carriers through specialized offerings in pharmacy distribution, clinical research support, and insurance brokerage. The company's Specialty Pharmacy Business focuses on offline pharmacy operations and pharmaceutical distribution, targeting pharmaceutical companies and distributors as key clients. Physician Research Assistance Business caters to pharmaceutical companies requiring regulatory-compliant clinical trial data for advancing drug development. Health Insurance Services Business partners with insurance carriers to distribute health and life insurance products to end customers, leveraging the company's brokerage platform for insurance product distribution. Sipai Health Technology's business model integrates pharmacy distribution, clinical research support, and insurance brokerage to address specific needs within the healthcare sector. The Specialty Pharmacy Business serves pharmaceutical companies and distributors with offline pharmacy networks and product distribution. Physician Research Assistance Business assists pharmaceutical companies in meeting regulatory requirements for clinical trials, while Health Insurance Services Business facilitates insurance product distribution through brokerage partnerships with carriers. Sipai Health Technology Co, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sipai Health Technology Co, stock

EBITDA per Share of Sipai Health Technology Co, is -0.39 CNY in 2024.

EBITDA per Share of Sipai Health Technology Co, changed from -0.33 CNY to -0.39 CNY, representing a 18.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Sipai Health Technology Co, since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Sipai Health Technology Co,

All Key Metrics — Sipai Health Technology Co,